Quan Wu
- Molecular Biology
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cell Biology top 10%
- Oncology
- Topics
- Retinal Diseases and Treatments (6 papers)Peptidase Inhibition and Analysis (5 papers)Histone Deacetylase Inhibitors Research (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Quan Wu
32 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 623
- Ophthalmology 291
- Radiology, Nuclear Medicine and Imaging 236
- Cell Biology 179
- Oncology 90
Countries citing papers authored by Quan Wu
This map shows the geographic impact of Quan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Wu more than expected).
Fields of papers citing papers by Quan Wu
This network shows the impact of papers produced by Quan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Wu. The network helps show where Quan Wu may publish in the future.
Co-authorship network of co-authors of Quan Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Quan Wu. A scholar is included among the top collaborators of Quan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Wu. Quan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 1 | |
| 4 | 48 | |
| 5 | 3 | |
| 6 | 50 | |
| 7 | 11 | |
| 8 | 36 | |
| 9 | 78 | |
| 10 | 10 | |
| 11 | 149 | |
| 12 | 31 | |
| 13 | 85 | |
| 14 | 35 | |
| 15 | 31 | |
| 16 | 26 | |
| 17 | 22 | |
| 18 | 65 | |
| 19 | 65 | |
| 20 | 18 |
About Quan Wu
Quan Wu is a scholar working on Ophthalmology, Hepatology and Molecular Biology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Ophthalmology (291 citations), Cell Biology (179 citations) and Radiology, Nuclear Medicine and Imaging (236 citations). Quan Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hongmei Luo, Zhiwei Wu, Wenting Li, Lejie Cao, Pingsheng Fan, Fengsong Wang, Ke Xiao, Shibo Tang, Xiaoling Liu and Chuanlong Zhu. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.